Meeting
2019 Genitourinary Cancers Symposium
Late toxicity described using patient reported outcomes measures (PROMS) in men treated with salvage radiation following primary high intensity focal ultrasound (HIFU) for localized prostate cancer.
Authors
Reena Davda
University College London Hospitals NHS Foundation Trust, London, AL, United Kingdom
Reena Davda , Clement Orczyk , Mark Prentice , Aylin Sarova , Manit Arya , Hashim Ahmed , Mark Emberton , Caroline Moore , Anita Mitra , Heather Ann Payne
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Prostate Cancer; Urothelial Carcinoma; Penile, Urethral, Testicular, and Adrenal Cancers
Track
Urothelial Carcinoma,Prostate Cancer,Penile, Urethral, Testicular, and Adrenal Cancers
Sub Track
Prostate Cancer - Localized Disease
Citation
J Clin Oncol 37, 2019 (suppl 7S; abstr 131)
DOI
10.1200/JCO.2019.37.7_suppl.131
Abstract #
131
Poster Bd #
C13
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Genitourinary Cancers Symposium
Long-term outcomes of a pilot study on highly hypofractionated intensity-modulated radiation therapy over three weeks for localized prostate cancer.
First Author: Kiyonao Nakamura
Poster
2020 Genitourinary Cancers Symposium
Five-year results from a phase I/II study of moderately hypofractionated intensity-modulated radiation therapy (IMRT) for localized prostate cancer including simultaneously integrated boost and pelvic lymph node (LN) coverage.
First Author: Anthony Ricco
Poster
2019 Genitourinary Cancers Symposium
Rectal toxicity results for patients treated with HDR brachytherapy as monotherapy versus dose-escalated external beam radiotherapy for localized prostate cancer.
First Author: Jacob Samuel Parzen
Poster
2019 Genitourinary Cancers Symposium
Moderately hypofractionated radiotherapy for localized prostate cancer: Long-term outcomes for 854 consecutive patients treated over 10 years (70 Gy in 2.5 Gy/fraction).
First Author: Omar Y. Mian